CHM
Click for more information
5.56% 1.9¢ chimeric therapeutics limited

Ann: 1st patient treated in ADVENT-AML Phase 1b clinical trial

  1. ASX News
    lightbulb Created with Sketch. 851
    clock Created with Sketch.
    08/02/24
    09:36
    Post #: 72297352
    Likes Created with Sketch. 51  Upvote
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

ALK Alkane Resources hit 57.2Kozpa gold production through FY24 – and eyeing 70Ktpa in FY26
right-arrow Created with Sketch.
EMD Emyria and UWA secure $499,411 grant to advance MDMA analogue drug program
right-arrow Created with Sketch.
BIO Biome posts record sales revenue of $13M in FY24 – up 80% vs pcp and higher than forecast
right-arrow Created with Sketch.
AHK Ark Mines defines significant exploration target at Sandy Mitchell rare earths project
right-arrow Created with Sketch.
ARU Cashed up Arafura locks in $171M German export agency deal; locks in NdPr offtake for wind turbines
right-arrow Created with Sketch.
ITM iTech lifts MRE at Eyre Peninsula Graphite Project by 300%
right-arrow Created with Sketch.
watchlist Created with Sketch. Add CHM (ASX) to my watchlist
(20min delay)
Last
1.9¢ 		Change
0.001(5.56%) 		Mkt cap ! $16.64M
Open High Low Value Volume
1.9¢ 1.9¢ 1.8¢ $13.35K 705.9K

Buyers (Bids)

No. Vol. Price($)
1 32333 1.9¢
 

Sellers (Offers)

Price($) Vol. No.
2.0¢ 1481067 6
View Market Depth
Last trade - 13.41pm 04/07/2024 (20 minute delay) ?
CHM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.